Genome-wide expression analysis of Middle Eastern colorectal cancer reveals FOXM1 as a novel target for cancer therapy

Shahab Uddin, Maqbool Ahmed, Azhar Hussain, Jehad Abubaker, Nasser Al-Sanea, Alaa AbdulJabbar, Luai H. Ashari, Samar Alhomoud, Fouad Al-Dayel, Zeenath Jehan, Prashant Bavi, Abdul K. Siraj, Khawla S. Al-Kuraya

Research output: Contribution to journalArticle

106 Citations (Scopus)

Abstract

To identify genes potentially playing an important role in the progression of colorectal carcinoma (CRC), we screened global gene expression using cDNA expression array on 41 CRC tissue samples and 25 noncancerous colorectal tissue samples. Among the up-regulated genes, forkhead box M1 (FOXM1) has been shown to play a critical role in pathogenesis of various malignancies. Using immunohistochemistry on 448 Saudi CRC samples in tissue microarray format, FoxM1 protein overexpression was seen in 66% of CRC tissues and was significantly associated with poorly differentiated and highly proliferative tumors (P = 0.0200 and 0.0018, respectively). FoxM1 expression was also significantly associated with MMP-9 protein expression (P = 0.0002). In vitro data using CRC cell lines showed that inhibition of FoxM1 by thiostrepton resulted in inhibition of proliferation and induction of apoptosis in a dose-dependent manner. Overexpression of FoxM1 potentiated cell proliferation, cell transformation, and migration/invasion of CRC cells via up-regulation of FoxM1 target genes MMP2 and MMP9 and protected these cells from thiostrepton-mediated antiproliferative effects. Finally, in vivo, over-expression of FoxM1 promoted growth of CRC-cell line xenograft tumors in nude mice. Altogether, our data indicate that FoxM1 signaling contributes to aggressiveness in a subset of CRC and that the FOXM1 gene may serve as a useful molecular biomarker and potential therapeutic target.

Original languageEnglish
Pages (from-to)537-547
Number of pages11
JournalAmerican Journal of Pathology
Volume178
Issue number2
DOIs
Publication statusPublished - 1 Jan 2011

Fingerprint Dive into the research topics of 'Genome-wide expression analysis of Middle Eastern colorectal cancer reveals FOXM1 as a novel target for cancer therapy'. Together they form a unique fingerprint.

  • Cite this

    Uddin, S., Ahmed, M., Hussain, A., Abubaker, J., Al-Sanea, N., AbdulJabbar, A., Ashari, L. H., Alhomoud, S., Al-Dayel, F., Jehan, Z., Bavi, P., Siraj, A. K., & Al-Kuraya, K. S. (2011). Genome-wide expression analysis of Middle Eastern colorectal cancer reveals FOXM1 as a novel target for cancer therapy. American Journal of Pathology, 178(2), 537-547. https://doi.org/10.1016/j.ajpath.2010.10.020